Intrauterine growth restriction and later cardiovascular function

Intrauterine growth restriction is one of the most common obstetric conditions, affecting 7-10% of fetuses. Affected fetuses are actually exposed in utero to an adverse environment during the highly critical time of development and may face life-long health consequences such as increased cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores: Crispi F, Crovetto F, Gratacos E
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:España
Institución:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:fsjd.fundanetsuite.com:p14965
Acceso en línea:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14965
Access Level:acceso abierto
Palabra clave:Intrauterine growth restriction
Fetal programming
Cardiovascular disease
Cardiovascular dysfunction
id ES_4d7525b421f6908e1e074e3370eeca1e
oai_identifier_str oai:fsjd.fundanetsuite.com:p14965
network_acronym_str ES
network_name_str España
repository_id_str
spelling Intrauterine growth restriction and later cardiovascular functionCrispi FCrovetto FGratacos EIntrauterine growth restrictionFetal programmingCardiovascular diseaseCardiovascular dysfunctionIntrauterine growth restriction is one of the most common obstetric conditions, affecting 7-10% of fetuses. Affected fetuses are actually exposed in utero to an adverse environment during the highly critical time of development and may face life-long health consequences such as increased cardiovascular risk in adulthood. Already in utero, fetuses affected by growth restriction show remodeled hearts with signs of systolic and diastolic dysfunction. Cardiovascular remodeling persist into postnatal life, from the neonatal period to adolescence, suggesting a primary fetal cardiac programming that might explain the increased cardiovascular risk later in life. In this review we summarize the current evidence on fetal cardiovascular programming in fetuses affected by growth restriction, its consequences later and possible strategies from which they could benefit to reduce their cardiovascular risk.ELSEVIER IRELAND LTD2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14965EARLY HUMAN DEVELOPMENTISSN: 03783782ISSNe: 18726232reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déuinstname:Fundació Sant Joan de DéuInglésinfo:eu-repo/semantics/openAccessoai:fsjd.fundanetsuite.com:p149652026-05-27T12:37:41Z
dc.title.none.fl_str_mv Intrauterine growth restriction and later cardiovascular function
title Intrauterine growth restriction and later cardiovascular function
spellingShingle Intrauterine growth restriction and later cardiovascular function
Crispi F
Intrauterine growth restriction
Fetal programming
Cardiovascular disease
Cardiovascular dysfunction
title_short Intrauterine growth restriction and later cardiovascular function
title_full Intrauterine growth restriction and later cardiovascular function
title_fullStr Intrauterine growth restriction and later cardiovascular function
title_full_unstemmed Intrauterine growth restriction and later cardiovascular function
title_sort Intrauterine growth restriction and later cardiovascular function
dc.creator.none.fl_str_mv Crispi F
Crovetto F
Gratacos E
author Crispi F
author_facet Crispi F
Crovetto F
Gratacos E
author_role author
author2 Crovetto F
Gratacos E
author2_role author
author
dc.subject.none.fl_str_mv Intrauterine growth restriction
Fetal programming
Cardiovascular disease
Cardiovascular dysfunction
topic Intrauterine growth restriction
Fetal programming
Cardiovascular disease
Cardiovascular dysfunction
description Intrauterine growth restriction is one of the most common obstetric conditions, affecting 7-10% of fetuses. Affected fetuses are actually exposed in utero to an adverse environment during the highly critical time of development and may face life-long health consequences such as increased cardiovascular risk in adulthood. Already in utero, fetuses affected by growth restriction show remodeled hearts with signs of systolic and diastolic dysfunction. Cardiovascular remodeling persist into postnatal life, from the neonatal period to adolescence, suggesting a primary fetal cardiac programming that might explain the increased cardiovascular risk later in life. In this review we summarize the current evidence on fetal cardiovascular programming in fetuses affected by growth restriction, its consequences later and possible strategies from which they could benefit to reduce their cardiovascular risk.
publishDate 2018
dc.date.none.fl_str_mv 2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14965
url https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14965
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER IRELAND LTD
publisher.none.fl_str_mv ELSEVIER IRELAND LTD
dc.source.none.fl_str_mv EARLY HUMAN DEVELOPMENT
ISSN: 03783782
ISSNe: 18726232
reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname:Fundació Sant Joan de Déu
instname_str Fundació Sant Joan de Déu
reponame_str r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
collection r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407692935659520
score 15,81155

Similares en LA Referencia